New technologies in screening for breast cancer: a systematic review of their accuracy

por Irwig, L, Houssami, N, van Vliet, C
Publicado 2004

Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3)

por Houssami, N, Ciatto, S, Bilous, M, Vezzosi, V, Bianchi, S
Publicado 2007

Second breast cancers in a Tuscan case series: characteristics, prognosis, and predictors of survival

por Ciatto, S, Houssami, N, Martinelli, F, Bonardi, R, Cafferty, F H, Duffy, S W
Publicado 2008

De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995

por Lord, SJ, Bahlmann, K, O'Connell, DL, Kiely, BE, Daniels, B, Pearson, SA, Beith, J, Bulsara, MK, Houssami, N
Publicado 2022

Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy

por Marinovich, M L, Macaskill, P, Irwig, L, Sardanelli, F, von Minckwitz, G, Mamounas, E, Brennan, M, Ciatto, S, Houssami, N
Publicado 2013

Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness

por de Bock, G H, Vermeulen, K M, Jansen, L, Oosterwijk, J C, Siesling, S, Dorrius, M D, Feenstra, T, Houssami, N, Greuter, M J W
Publicado 2013

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)

por Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., Cardoso, M. J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S. H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U. N., Mayer, M., Merjaver, S. D., Nordström, E. B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M. J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Publicado 2014